NCT03351816View on ClinicalTrials.gov

Impact of New Biomarkers on Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation

NACompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

March 31, 2019

Study Completion Date

June 1, 2020

Conditions

Atrial Fibrillation

Interventions

PROCEDURE

Ablation of atrial fibrillation

Pulmonary vein isolation by radiofrequency or cryoablation.

PROCEDURE

Cardioversion

External electric shock delivery under general anesthesia.

Trial Locations (3)

25000

University Hospital Jean Minjoz, Besançon

Unknown

CHU François Mitterand, Dijon

CHU Brabois, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT03351816 - Impact of New Biomarkers on Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation | Biotech Hunter | Biotech Hunter